Left Atrial Appendage (LAA) Occluders

This channel includes news and new technology innovations about Left Atrial Appendage (LAA) Occluders. These close off the LAA in patients with atrial fibrillation to prevent the formation of stroke-causing clots in atrial fibrillation (AFib or AF) patients. LAA occlusion is often indicated for patients who do not tolerate anticoagulation therpy or have bleeding risks associated with use of that therapy.

News | June 17, 2010
June 17, 2010 – AGA Medical Holdings Inc. this week announced first patient enrollment in the feasibility phase of...
Technology | June 16, 2010
June 16, 2010 – A new surgical device for excluding the left atrial appendage has received clearance from the U.S....
News | March 25, 2010
March 25, 2010 – The FDA this week granted permission for a conditional investigational device exemption (IDE) to...

LARIAT Suture Delivery Device

News | August 23, 2009
August 24, 2009 – Physicians at The Mount Sinai Medical Center were the first in the country to perform a nonsurgical...
News | May 11, 2009
May 11, 2009 - Medtronic Inc. today announced the successful implant of its Cardioblate Closure Left Atrial Appendage...
Feature | April 02, 2009
April 2, 2009 - A device implanted in the heart using minimally invasive techniques may replace the most widely...
News | March 06, 2009
March 6, 2009 - Atritech Inc. will release PROTECT AF trial results on WATCHMAN LAA closure technology comparing the...
News | August 18, 2008
August 18, 2008 - Atritech Inc. today said it filed its pre-market approval application (PMA) with the FDA for its...
Technology | May 08, 2007
The Watchman device is designed to keep harmful sized blood clots that form in the left atrial appendage from...